Rigel Pharmaceuticals Inc (RIGL) — Cash Flow-to-Debt Ratio
Rigel Pharmaceuticals Inc (RIGL) has a Cash Flow-to-Debt Ratio of 0.03x as of March 2026, meaning its operating cash flow of $2.73 Million could theoretically repay 0% of its total liabilities ($104.71 Million) in one year. Check Rigel Pharmaceuticals Inc (RIGL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Rigel Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1999–2025)
Historical debt coverage capacity for Rigel Pharmaceuticals Inc across 27 annual periods. Also explore RIGL total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Rigel Pharmaceuticals Inc (1999–2025)
Year-by-year debt coverage analysis for Rigel Pharmaceuticals Inc. For market capitalisation and broader financial context, see Rigel Pharmaceuticals Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.62x | $75.66 Million | $122.11 Million | ▲ +216.3% |
| 2024 | 0.20x | $31.47 Million | $160.69 Million | ▲ +597.5% |
| 2023 | -0.04x | $-5.74 Million | $145.87 Million | ▲ +92.1% |
| 2022 | -0.50x | $-73.76 Million | $147.90 Million | ▼ -1262.0% |
| 2021 | 0.04x | $5.88 Million | $136.95 Million | ▲ +106.3% |
| 2020 | -0.68x | $-52.19 Million | $76.35 Million | ▼ -54.4% |
| 2019 | -0.44x | $-41.51 Million | $93.75 Million | ▲ +78.0% |
| 2018 | -2.01x | $-58.83 Million | $29.23 Million | ▲ +52.1% |
| 2017 | -4.20x | $-77.56 Million | $18.46 Million | ▼ -27.9% |
| 2016 | -3.28x | $-75.89 Million | $23.11 Million | ▼ -466.2% |
| 2015 | -0.58x | $-23.41 Million | $40.37 Million | ▲ +78.5% |
| 2014 | -2.69x | $-69.75 Million | $25.89 Million | ▲ +44.3% |
| 2013 | -4.83x | $-86.06 Million | $17.81 Million | ▼ -18.8% |
| 2012 | -4.07x | $-85.19 Million | $20.95 Million | ▼ -22.9% |
| 2011 | -3.31x | $-69.38 Million | $20.96 Million | ▼ -245.6% |
| 2010 | 2.27x | $46.74 Million | $20.56 Million | ▲ +168.3% |
| 2009 | -3.33x | $-102.78 Million | $30.88 Million | ▼ -27.6% |
| 2008 | -2.61x | $-103.52 Million | $39.69 Million | ▼ -67.9% |
| 2007 | -1.55x | $-52.21 Million | $33.61 Million | ▼ -12.8% |
| 2006 | -1.38x | $-35.84 Million | $26.01 Million | ▼ -53.1% |
| 2005 | -0.90x | $-35.17 Million | $39.08 Million | ▲ +37.4% |
| 2004 | -1.44x | $-38.15 Million | $26.52 Million | ▲ +31.0% |
| 2003 | -2.09x | $-32.44 Million | $15.55 Million | ▼ -14.2% |
| 2002 | -1.83x | $-34.53 Million | $18.90 Million | ▼ -100.1% |
| 2001 | -0.91x | $-15.98 Million | $17.51 Million | ▼ -20.1% |
| 2000 | -0.76x | $-11.59 Million | $15.25 Million | ▼ -59.2% |
| 1999 | -0.48x | $-7.83 Million | $16.41 Million | — |